Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trial

Overview of attention for article published in Archives of Orthopaedic and Trauma Surgery, May 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#48 of 1,379)
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

policy: 2 policy sources

twitter: 15 X users

Citations

dimensions_citation: 89 Dimensions

Readers on

mendeley: 103 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 4 policy documents that reference this research output.

Joint replacement (primary): hip, knee and shoulder : G: Tranexamic acid to minimise blood loss

Cited by National Institute for Health and Care Excellence on 28 May 2020

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Joint replacement (primary): hip, knee and shoulder : Network meta-analysis and cost analysis of methods for tranexamic acid administration

Cited by National Institute for Health and Care Excellence on 28 May 2020

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Blood transfusion : Appendix A: Summary of evidence from surveillance

Cited by National Institute for Health and Care Excellence on 02 Mar 2020

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Prophylactic Tranexamic Acid Administration for Patients Undergoing Hip and Knee Replacement: Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Cited by Canadian Agency for Drugs and Technologies in Health on 16 Jun 2015

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.